ITR Search | International Tax Review

US extenders Bill passes Senate, awaits Obama signature

The US Senate voted this week to approve a one-year retroactive extension of certain temporary tax provisions that expired at the end of last year, including the research and experimentation credit.

Matthew Gilleard, December 18 2014

Finance Bill gives UK tax authorities more weapons against reluctant taxpayers

The UK tax authorities expect taxpayers will spend about £200,000 ($314,000) annually to comply with UK rules on country-by-country reporting (CbCR).

December 17 2014

Despite progress, Indian tax professionals say GST by 2016 is ‘close to impossible’

Even if Arun Jaitley succeeds in tabling a bill in parliament by the end of the year to introduce national GST in India, tax professionals say the government’s 15 month time frame for introducing the tax on April 1 2016 is not viable.

December 18 2014

European Commission to seek information on tax rulings from all member states

The European Commission has expanded its state aid inquiry into tax rulings to cover all 28 EU member states.

Joe Stanley-Smith, December 17 2014

Luxembourg to keep €1.1 billion of VAT due to phased implementation

Luxembourg will keep around €1.1 billion ($1.4 billion) of the losses it would incur as a result of the EU’s VAT changes over the next four years.

Joe Stanley-Smith, December 18 2014

The big moves of 2014

A string of departures by senior Internal Revenue Service figures dominated the comings and goings among tax professionals in 2014.

December 19 2014

Common Reporting Standard grabs 2014 headlines

One event dominated the world of tax compliance and administration this year: the signing of the multilateral competent authority agreement in Berlin on October 29 to enable the Common Reporting Standard (CRS), the global standard for the automatic exchange of tax information, to operate.

Ralph Cunningham, December 19 2014

Clare Hartnell arrives at FTI Consulting

Clare Hartnell has joined FTI Consulting as a senior managing director in the firm’s European tax advisory practice.

December 18 2014

Pfizer and AstraZeneca go separate ways…for now

After the failure of the Pfizer-AstraZeneca transaction at the end of May, the two companies have now announced new deals with other companies. But the drugs companies could return to the proposed inversion deal later this month.

Matthew Gilleard, August 28 2014

Inverted views of morality

The number of US companies inverting to a lower-taxed jurisdiction has created another form of peer pressure. Shareholders are seeing rival companies successfully restructure, and many are now pondering the question: to invert or not to invert.

August 28 2014

Search results for